TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,140.81−0.59%Brent$109.22−0.54%BTC$81,945.77−0.08%ETH$2,400.67−0.28%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,140.81−0.59%Brent$109.22−0.54%BTC$81,945.77−0.08%ETH$2,400.67−0.28%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Gilead Sciences Inc · Overview · TradingHolo

Markets › United States › NAS › GILD

G

Gilead Sciences Inc

NAS:GILDHealthcareCBOE:SPESGNASDAQ:NBI

$153.12−1.97%At closeAt close · Mon 19 Oct · ≈ AED 562.31 · Market cap $189.86B · Next earnings Thu 29 Oct

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−2.0%

1M

+3.5%

3M

+17.3%

6M

+13.5%

1Y

+32.0%

Why it's moving today

Gilead hits mid-stage trial success for oral bowel disease therapy

Seeking Alpha · Mon 19 Oct

✦ This week in three lines

No written digest yet for GILD. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +3.6%

Valuation

P/E vs sector22.8× vs −1.7×

Price / Book vs sector8.6× vs 2.0×

Price / Sales vs sector6.6× vs 3.9×

Price / Free cash flow vs sector20.5× vs −1.6×

cheap for itself (11.5×)expensive for itself (1,075.8×)

Forecasts

23 buy6 hold1 sell30 analysts

Average target$142.00 −7.3%

Analysts5

EPS surprises, last 87 beats

Dividends

Yield2.1%

Annual payout$3.25

Payout ratio47.0%

Next ex-date—

Years of growth9

Latest news

All GILD news →

SEGilead hits mid-stage trial success for oral bowel disease therapy

Seeking Alpha · 7 h ago

BUGilead to Present New Data Across HIV and Emerging Antiviral Research at IDWeek 2026

BusinessWire · 10 h ago

REGilead - Emvistegrast 200 Mg Met The Primary Endpoint In Phase 2 Swift Dose-Ranging Study

Reuters · 10 h ago

Key facts

At close · Mon 19 Oct

Market cap (USD)$189.86B

P/E22.8×

Dividend yield2.1%

52-week range$114.02 – $160.51

Avg volume (20d)5,543,532

Shares outstanding1,239,960,000

Beta0.34

Short interest1.8% of float

Next earningsThu 29 Oct

Radar Score

80

Value51

Quality93

Momentum78

Income97

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×−1.03%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×−0.72%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×−0.78%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×+1.35%